التفاصيل البيبلوغرافية
العنوان: |
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival |
المؤلفون: |
James Larkin, Jeffrey Weber, Victoria Atkinson, Michael Millward, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Helen Gogas, Paolo A Ascierto, Anna Maria Di Giacomo, Veerle de Pril, Vanna Chiarion-Sileni, Stephane Dalle, Leslie Fecher, Ana Arance, Jean-Jacques Grob, Nikhil I Khushalani, Michele Del Vecchio, Mario Mandala, C Lance Cowey, Michael Schenker, Petr Arenberger, Maurice Lobo |
المصدر: |
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021) |
بيانات النشر: |
BMJ Publishing Group, 2021. |
سنة النشر: |
2021 |
المجموعة: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
نوع الوثيقة: |
article |
وصف الملف: |
electronic resource |
اللغة: |
English |
تدمد: |
2051-1426 |
العلاقة: |
https://jitc.bmj.com/content/9/8/e003188.fullTest; https://doaj.org/toc/2051-1426Test |
DOI: |
10.1136/jitc-2021-003188 |
الوصول الحر: |
https://doaj.org/article/c281f8a682984c818531f79c5352985aTest |
رقم الانضمام: |
edsdoj.281f8a682984c818531f79c5352985a |
قاعدة البيانات: |
Directory of Open Access Journals |